Medicina y Especialidades Médicas

2016

1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

   Russian Journal of Cardiology, Vol. 131, Núm. 3, pp. 9-63

2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC)

   European Heart Journal, Vol. 37, Núm. 3, pp. 267-315

3. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)

   Giornale Italiano di Cardiologia, Vol. 17, Núm. 2, pp. 108-170

4. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

   European Heart Journal, Vol. 37, Núm. 1, pp. 67-119

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC

   European Journal of Heart Failure, Vol. 18, Núm. 8, pp. 891-975

6. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

   European Heart Journal, Vol. 37, Núm. 38

7. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

   Europace, Vol. 18, Núm. 11, pp. 1609-1678

8. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

   European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 50, Núm. 5, pp. e1-e88

9. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

   European Heart Journal, Vol. 37, Núm. 36, pp. 2768-2801

10. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1167.-1167.

11. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    European Heart Journal, Vol. 37, Núm. 39, pp. 2999-3058l

12. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)

    Atherosclerosis, Vol. 253, pp. 281-344

13. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

    European Heart Journal, Vol. 37, Núm. 29, pp. 2315-2381

14. 2016 European Guidelines on cardiovascular disease prevention in clinical practice the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

    European Journal of Preventive Cardiology, Vol. 23, Núm. 11, pp. NP1-NP96

15. 3D silicon doped hydroxyapatite scaffolds decorated with Elastin-like Recombinamers for bone regenerative medicine

    Acta Biomaterialia, Vol. 45, pp. 349-356

16. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

17. A collaborative system for endovascular treatment of acute ischaemic stroke: The Madrid Stroke Network experience

    European Journal of Neurology, Vol. 23, Núm. 2, pp. 297-303

18. A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma

    Leukemia and Lymphoma, Vol. 57, Núm. 8, pp. 1848-1855

19. A nontargeted study of muscle proteome in severely obese women with androgen excess compared with severely obese men and nonhyperandrogenic women

    European Journal of Endocrinology, Vol. 174, Núm. 3, pp. 389-398

20. A randomised controlled trial on the efficacy of a multidisciplinary health care team on morbidity and mortality of elderly patients attending the Emergency Department. Study design and preliminary results

    Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 371-384